Home/Filings/4/0000950170-24-133260
4//SEC Filing

Huller Kelly 4

Accession 0000950170-24-133260

CIK 0001237831other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 4:12 PM ET

Size

8.7 KB

Accession

0000950170-24-133260

Insider Transaction Report

Form 4
Period: 2024-12-02
Huller Kelly
EVP, GC, Corporate Secretary
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy Class A Common Stock)

    2024-12-022,5000 total
    Exercise: $24.21Exp: 2026-02-02Class A Common Stock (2,500 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2024-12-02$24.21/sh+2,500$60,5252,500 total
  • Sale

    Class A Common Stock

    2024-12-02$87.00/sh2,500$217,5020 total
Footnotes (3)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 13, 2024 executed by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.00 to $87.075, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]These options were granted on February 2, 2016 and are fully vested.

Documents

1 file

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeother

Related Parties

1
  • filerCIK 0001768417

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:12 PM ET
Size
8.7 KB